Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases.
OBJECTIVE
To develop a Western blot method for quantification of multiple aggrecan fragments in human synovial fluids (SFs).


METHODS
SF aggrecan fragments were prepared from knee healthy (reference), knee injury and arthritis subjects by CsCl gradient centrifugations collecting D1 fractions. Samples were analyzed by Western blot, using antibodies against the N-terminal epitope ARGS and the G3 domain, and fragments were quantified using a digital luminescence image analyzer.


RESULTS
The method had a coefficients of variation of 10-30%, and a high correlation (r(S)=0.86) with a corresponding enzyme-linked immunosorbent assay (ELISA). The SFs from reference, knee injured and arthritic subjects contained two major ARGS fragments, ARGS-SELE and ARGS-CS1, and three major G3 fragments (GRGT-G3, GLGS-G3 and AGEG-G3). Compared to the reference, the acute arthritis and acute joint injury groups had a 30-fold elevated concentration of ARGS fragments, and both groups had a higher proportion of the aggrecan in joint fluid as ARGS fragments compared to the other groups. The reference and chronic injury groups had an excess of ARGS-CS1 fragments over ARGS-SELE fragments, while subjects with acute arthritis or osteoarthritis had a more even distribution between these fragments.


CONCLUSIONS
We have developed a novel Western blot quantification method for quantification of SF aggrecan fragments which can differentiate fragments of different sizes sharing the same epitope. The anti-ARGS and anti-G3 quantitative Western blots provided information important for a better understanding of the proteolytic pathways in aggrecan breakdown, information that discriminates between different joint diseases, and may aid in identification of new biomarkers.
Struglics
A
A
Department of Orthopaedics, Clinical Sciences Lund, Lund University, Sweden. andre.struglics@med.lu.se
Larsson
S
S
Hansson
M
M
Lohmander
L S
LS
D000328:Adult; D000368:Aged; D053674:Aggrecans / Q000378:metabolism*; D015153:Blotting, Western / Q000379:methods; D010450:Endopeptidases / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007718:Knee Injuries / Q000378:metabolism*; D007719:Knee Joint / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D020370:Osteoarthritis, Knee / Q000378:metabolism*; D013582:Synovial Fluid / Q000378:metabolism*; D055815:Young Adult
D053674:Aggrecans; D010450:Endopeptidases; C083641:aggrecanase